Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 8,965-8,976 of 10,592
Drug study icon
TerminatedNCT00746252

Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolarity

This study exists to explore whether the medication Antipsychotic could improve care and understanding. Researchers are trying to understand whether the medication Antipsychotic can give earlier or clearer feedback during care.

In United States
BipolarityDrugA study involving a medication or substance.From 7 Years to 12 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Bipolarity
Drug study icon
CompletedNCT00363181

Side Effects of Antipsychotic Medications

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaOtherFrom 30 Years to 66 Years
Countries
United States
Sponsor
Stanford University
Condition
Schizophrenia
Drug study icon
CompletedNCT00245206

Side Effects of Newer Antipsychotics in Older Adults

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugOver 40 Years
Countries
United States
Sponsor
Veterans Medical Research Foundation
Condition
Schizophrenia
Drug study icon
TerminatedNCT01665950

Simvastatin Augmentation of Lithium Treatment in Depression in bipolarity

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

In United States
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT03002961

Single Ascending Dose Study of RBP-6000

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Indivior Inc.
Condition
Addiction
Drug study icon
CompletedNCT02768649

Single Ascending Dose Study of RBP-7000

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Indivior Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.